FLUOGUIDE A/S DK -1 (96X) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.092x

Based on the latest financial reports, FLUOGUIDE A/S DK -1 (96X) has a cash flow conversion efficiency ratio of -0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.03 Million ≈ $-5.88 Million USD) by net assets (€54.53 Million ≈ $63.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can FLUOGUIDE A/S DK -1 fund operations to measure how many days the company can operate on defensive assets alone.

FLUOGUIDE A/S DK -1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how FLUOGUIDE A/S DK -1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

FLUOGUIDE A/S DK -1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of FLUOGUIDE A/S DK -1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
XTI Aerospace, Inc.
NASDAQ:XTIA
-0.205x
Elron Electronic Industries Ltd
TA:ELRN
-0.005x
Savezone I C
KO:067830
-0.003x
Midsummer AB (publ)
ST:MIDS
-0.108x
Tirupati Forge Limited
NSE:TIRUPATIFL
-0.024x
Derluks Yatirim Holding AS
IS:DERHL
-0.015x
Jinhui Shipping and Transportation Limited
F:J4O
0.038x
Young Bag Micro Motors Co Ltd
KQ:193250
-0.038x

Annual Cash Flow Conversion Efficiency for FLUOGUIDE A/S DK -1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of FLUOGUIDE A/S DK -1.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €54.53 Million
≈ $63.75 Million
€-36.96 Million
≈ $-43.21 Million
-0.678x +46.37%
2024-12-31 €23.07 Million
≈ $26.97 Million
€-29.15 Million
≈ $-34.08 Million
-1.264x +49.46%
2023-12-31 €12.72 Million
≈ $14.87 Million
€-31.81 Million
≈ $-37.19 Million
-2.501x -112.36%
2022-12-31 €31.97 Million
≈ $37.37 Million
€-37.65 Million
≈ $-44.01 Million
-1.178x -202.57%
2021-12-31 €38.70 Million
≈ $45.25 Million
€-15.06 Million
≈ $-17.61 Million
-0.389x --

About FLUOGUIDE A/S DK -1

F:96X Germany Biotechnology
Market Cap
$73.21 Million
€62.62 Million EUR
Market Cap Rank
#21225 Global
#1916 in Germany
Share Price
€3.83
Change (1 day)
-0.26%
52-Week Range
€2.68 - €4.06
All Time High
€13.84
About

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more